2023 Q3 Form 10-Q Financial Statement
#000149315223029131 Filed on August 16, 2023
Income Statement
Concept | 2023 Q3 | 2023 Q2 | 2022 Q2 |
---|---|---|---|
Revenue | $0.00 | $0.00 | |
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $421.5K | $199.6K | |
YoY Change | |||
% of Gross Profit | |||
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | |||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $421.5K | $199.6K | |
YoY Change | |||
Operating Profit | -$421.5K | -$199.6K | |
YoY Change | |||
Interest Expense | $579.4K | $815.9K | |
YoY Change | |||
% of Operating Profit | |||
Other Income/Expense, Net | $579.4K | $815.9K | |
YoY Change | |||
Pretax Income | $157.9K | $616.3K | |
YoY Change | |||
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | $157.9K | $616.3K | |
YoY Change | |||
Net Earnings / Revenue | |||
Basic Earnings Per Share | $0.02 | $0.07 | $0.00 |
Diluted Earnings Per Share | $0.02 | $0.07 | $0.00 |
COMMON SHARES | |||
Basic Shares Outstanding | 8.941M shares | 8.941M shares | 1.500M shares |
Diluted Shares Outstanding | 6.600M shares | 6.600M shares | 1.500M shares |
Balance Sheet
Concept | 2023 Q3 | 2023 Q2 | 2022 Q2 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $26.52K | $370.1K | |
YoY Change | |||
Cash & Equivalents | $26.52K | $370.1K | |
Short-Term Investments | |||
Other Short-Term Assets | $58.63K | $91.81K | |
YoY Change | |||
Inventory | |||
Prepaid Expenses | $58.63K | $91.81K | |
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $85.16K | $461.9K | |
YoY Change | |||
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | $70.63M | $69.39M | |
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $70.63M | $69.39M | |
YoY Change | |||
TOTAL ASSETS | |||
Total Short-Term Assets | $85.16K | $461.9K | |
Total Long-Term Assets | $70.63M | $69.39M | |
Total Assets | $70.71M | $69.85M | |
YoY Change | 27442.14% | ||
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $1.289M | ||
YoY Change | |||
Accrued Expenses | $383.7K | $108.9K | |
YoY Change | 420.7% | ||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $1.169M | $463.9K | |
YoY Change | 337.9% | ||
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | |
YoY Change | |||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | $0.00 | $0.00 | |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $1.169M | $463.9K | |
Total Long-Term Liabilities | $0.00 | $0.00 | |
Total Liabilities | $1.169M | $463.9K | |
YoY Change | 337.9% | ||
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$1.084M | -$2.210K | |
YoY Change | 10614.82% | ||
Common Stock | $167.00 | $242.00 | |
YoY Change | -3.47% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$1.083M | -$1.968K | -$10.11K |
YoY Change | |||
Total Liabilities & Shareholders Equity | $70.71M | $69.85M | |
YoY Change | 27442.14% |
Cashflow Statement
Concept | 2023 Q3 | 2023 Q2 | 2022 Q2 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | $157.9K | $616.3K | |
YoY Change | |||
Depreciation, Depletion And Amortization | |||
YoY Change | |||
Cash From Operating Activities | -$112.5K | -$100.3K | |
YoY Change | |||
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | -$660.0K | ||
YoY Change | |||
Cash From Investing Activities | -$660.0K | ||
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 429.9K | 350.0K | |
YoY Change | |||
NET CHANGE | |||
Cash From Operating Activities | -112.5K | -100.3K | |
Cash From Investing Activities | -660.0K | ||
Cash From Financing Activities | 429.9K | 350.0K | |
Net Change In Cash | -342.6K | 249.7K | |
YoY Change | |||
FREE CASH FLOW | |||
Cash From Operating Activities | -$112.5K | -$100.3K | |
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001851484 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
CY2022Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
usd | |
CY2023Q2 | us-gaap |
Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
|
http://fasb.org/us-gaap/2023#RelatedPartyMember | |
CY2022Q4 | us-gaap |
Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
|
http://fasb.org/us-gaap/2023#RelatedPartyMember | |
CY2023Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2022Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2023Q2 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2022Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2023Q2 | TENK |
Shareholder Receivable
ShareholderReceivable
|
usd | |
CY2022Q4 | TENK |
Shareholder Receivable
ShareholderReceivable
|
usd | |
CY2022Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
usd | ||
CY2022Q2 | TENK |
Interest Income On Investments Held In Trust
InterestIncomeOnInvestmentsHeldInTrust
|
usd | |
TENK |
Interest Income On Investments Held In Trust
InterestIncomeOnInvestmentsHeldInTrust
|
usd | ||
CY2023Q2 | TENK |
Changes In Derivative Liabilities
ChangesInDerivativeLiabilities
|
usd | |
CY2022Q2 | TENK |
Changes In Derivative Liabilities
ChangesInDerivativeLiabilities
|
usd | |
TENK |
Changes In Derivative Liabilities
ChangesInDerivativeLiabilities
|
usd | ||
TENK |
Changes In Derivative Liabilities
ChangesInDerivativeLiabilities
|
usd | ||
CY2022Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
usd | |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
usd | ||
CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
usd | ||
TENK |
Weighted Average Ordinary Shares Outstanding Basic For Ordinary Shares Subject To Redemption
WeightedAverageOrdinarySharesOutstandingBasicForOrdinarySharesSubjectToRedemption
|
shares | ||
CY2022Q2 | TENK |
Weighted Average Ordinary Shares Outstanding Diluted For Ordinary Shares Subject To Redemption
WeightedAverageOrdinarySharesOutstandingDilutedForOrdinarySharesSubjectToRedemption
|
shares | |
TENK |
Weighted Average Ordinary Shares Outstanding Diluted For Ordinary Shares Subject To Redemption
WeightedAverageOrdinarySharesOutstandingDilutedForOrdinarySharesSubjectToRedemption
|
shares | ||
CY2022Q2 | TENK |
Weighted Average Ordinary Shares Outstanding Basic For Ordinary Shares Subject To Redemption
WeightedAverageOrdinarySharesOutstandingBasicForOrdinarySharesSubjectToRedemption
|
shares | |
TENK |
Weighted Average Ordinary Shares Outstanding Basic For Ordinary Shares Subject To Redemption
WeightedAverageOrdinarySharesOutstandingBasicForOrdinarySharesSubjectToRedemption
|
shares | ||
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
usd | |
CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
usd | |
CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
usd | ||
TENK |
Interest Income On Investments Held In Trust
InterestIncomeOnInvestmentsHeldInTrust
|
usd | ||
us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
usd | ||
TENK |
Increase Decrease Formation And Organization Costs Paid By Related Parties
IncreaseDecreaseFormationAndOrganizationCostsPaidByRelatedParties
|
usd | ||
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
usd | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
usd | ||
us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
usd | ||
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
usd | ||
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
usd | ||
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
usd | |
CY2022Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
usd | |
TENK |
Remeasurement Of Ordinary Shares Subject To Redemption
RemeasurementOfOrdinarySharesSubjectToRedemption
|
usd | ||
TENK |
Deferred Offering Costs Included In Accrued Expenses
DeferredOfferingCostsIncludedInAccruedExpenses
|
usd | ||
TENK |
Deferred Offering Costs Included In Due To Related Party
DeferredOfferingCostsIncludedInDueToRelatedParty
|
usd | ||
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-06-30 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
001-41534 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
TenX Keane Acquisition | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
E9 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
420 Lexington Ave | ||
dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 2446 | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
New York | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
NY | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
10170 | ||
dei |
City Area Code
CityAreaCode
|
(347) | ||
dei |
Local Phone Number
LocalPhoneNumber
|
627-0058 | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | ||
dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
true | ||
CY2023Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
8941000 | shares |
CY2023Q2 | us-gaap |
Cash
Cash
|
370095 | usd |
CY2022Q4 | us-gaap |
Cash
Cash
|
289175 | usd |
CY2023Q2 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
91812 | usd |
CY2022Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
88169 | usd |
CY2023Q2 | us-gaap |
Assets Current
AssetsCurrent
|
461907 | usd |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
377344 | usd |
CY2023Q2 | us-gaap |
Long Term Investments
LongTermInvestments
|
69388517 | usd |
CY2022Q4 | us-gaap |
Long Term Investments
LongTermInvestments
|
67813020 | usd |
CY2023Q2 | us-gaap |
Assets
Assets
|
69850424 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
68190364 | usd |
CY2023Q2 | TENK |
Accrued Offering Costs
AccruedOfferingCosts
|
5001 | usd |
CY2022Q4 | TENK |
Accrued Offering Costs
AccruedOfferingCosts
|
31836 | usd |
CY2023Q2 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
108899 | usd |
CY2023Q2 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
349975 | usd |
CY2023Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
463875 | usd |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
31836 | usd |
CY2023Q2 | us-gaap |
Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares
|
6600000 | shares |
CY2022Q4 | us-gaap |
Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares
|
6600000 | shares |
CY2023Q2 | us-gaap |
Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
|
10.51 | |
CY2022Q4 | us-gaap |
Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
|
10.27 | |
CY2023Q2 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
69388517 | usd |
CY2022Q4 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
67813020 | usd |
CY2023Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | shares |
CY2023Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2023Q2 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2023Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000 | shares |
CY2023Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
2416000 | shares |
CY2023Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
2416000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
2416000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
2416000 | shares |
CY2023Q2 | us-gaap |
Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares
|
6600000 | shares |
CY2022Q4 | us-gaap |
Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares
|
6600000 | shares |
CY2023Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
242 | usd |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
242 | usd |
CY2023Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
242 | usd |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
242 | usd |
CY2023Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-2210 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
345266 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1968 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
345508 | usd |
CY2023Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
69850424 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
68190364 | usd |
CY2023Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
199554 | usd |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
347476 | usd | |
CY2023Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-199554 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-347476 | usd | |
CY2023Q2 | TENK |
Interest Income On Investments Held In Trust
InterestIncomeOnInvestmentsHeldInTrust
|
815850 | usd |
TENK |
Interest Income On Investments Held In Trust
InterestIncomeOnInvestmentsHeldInTrust
|
1575497 | usd | |
CY2023Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
815850 | usd |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
1575497 | usd | |
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
616296 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
1228021 | usd | |
CY2023Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
6600000 | shares |
CY2023Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
6600000 | shares |
CY2022Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
1500000 | shares |
CY2022Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
1500000 | shares |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
6600000 | shares | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
6600000 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
1500000 | shares | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
1500000 | shares | |
CY2023Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
6600000 | shares |
CY2022Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
1500000 | shares |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
6600000 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
1500000 | shares | |
CY2023Q2 | TENK |
Basic Net Income Per Ordinary Share For Ordinary Shares Not Subject To Redemption
BasicNetIncomePerOrdinaryShareForOrdinarySharesNotSubjectToRedemption
|
0.07 | |
CY2023Q2 | TENK |
Diluted Net Income Per Ordinary Share For Ordinary Shares Not Subject To Redemption
DilutedNetIncomePerOrdinaryShareForOrdinarySharesNotSubjectToRedemption
|
0.07 | |
CY2022Q2 | TENK |
Basic Net Income Per Ordinary Share For Ordinary Shares Not Subject To Redemption
BasicNetIncomePerOrdinaryShareForOrdinarySharesNotSubjectToRedemption
|
0.00 | |
CY2022Q2 | TENK |
Diluted Net Income Per Ordinary Share For Ordinary Shares Not Subject To Redemption
DilutedNetIncomePerOrdinaryShareForOrdinarySharesNotSubjectToRedemption
|
0.00 | |
TENK |
Basic Net Income Per Ordinary Share For Ordinary Shares Not Subject To Redemption
BasicNetIncomePerOrdinaryShareForOrdinarySharesNotSubjectToRedemption
|
0.14 | ||
TENK |
Diluted Net Income Per Ordinary Share For Ordinary Shares Not Subject To Redemption
DilutedNetIncomePerOrdinaryShareForOrdinarySharesNotSubjectToRedemption
|
0.14 | ||
TENK |
Basic Net Income Per Ordinary Share For Ordinary Shares Not Subject To Redemption
BasicNetIncomePerOrdinaryShareForOrdinarySharesNotSubjectToRedemption
|
0.00 | ||
TENK |
Diluted Net Income Per Ordinary Share For Ordinary Shares Not Subject To Redemption
DilutedNetIncomePerOrdinaryShareForOrdinarySharesNotSubjectToRedemption
|
0.00 | ||
CY2023Q2 | TENK |
Basic Net Income Per Ordinary Share For Ordinary Shares Not Subject To Redemption
BasicNetIncomePerOrdinaryShareForOrdinarySharesNotSubjectToRedemption
|
0.07 | |
CY2022Q2 | TENK |
Basic Net Income Per Ordinary Share For Ordinary Shares Not Subject To Redemption
BasicNetIncomePerOrdinaryShareForOrdinarySharesNotSubjectToRedemption
|
0.00 | |
TENK |
Basic Net Income Per Ordinary Share For Ordinary Shares Not Subject To Redemption
BasicNetIncomePerOrdinaryShareForOrdinarySharesNotSubjectToRedemption
|
0.14 | ||
TENK |
Basic Net Income Per Ordinary Share For Ordinary Shares Not Subject To Redemption
BasicNetIncomePerOrdinaryShareForOrdinarySharesNotSubjectToRedemption
|
0.00 | ||
CY2023Q2 | TENK |
Weighted Average Ordinary Shares Outstanding Basic For Ordinary Shares Subject To Redemption
WeightedAverageOrdinarySharesOutstandingBasicForOrdinarySharesSubjectToRedemption
|
2416000 | shares |
CY2023Q2 | TENK |
Weighted Average Ordinary Shares Outstanding Diluted For Ordinary Shares Subject To Redemption
WeightedAverageOrdinarySharesOutstandingDilutedForOrdinarySharesSubjectToRedemption
|
2416000 | shares |
TENK |
Weighted Average Ordinary Shares Outstanding Basic For Ordinary Shares Subject To Redemption
WeightedAverageOrdinarySharesOutstandingBasicForOrdinarySharesSubjectToRedemption
|
2416000 | shares | |
TENK |
Weighted Average Ordinary Shares Outstanding Diluted For Ordinary Shares Subject To Redemption
WeightedAverageOrdinarySharesOutstandingDilutedForOrdinarySharesSubjectToRedemption
|
2416000 | shares | |
CY2023Q2 | TENK |
Weighted Average Ordinary Shares Outstanding Basic For Ordinary Shares Subject To Redemption
WeightedAverageOrdinarySharesOutstandingBasicForOrdinarySharesSubjectToRedemption
|
2416000 | shares |
TENK |
Weighted Average Ordinary Shares Outstanding Basic For Ordinary Shares Subject To Redemption
WeightedAverageOrdinarySharesOutstandingBasicForOrdinarySharesSubjectToRedemption
|
2416000 | shares | |
CY2023Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.07 | |
CY2023Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.07 | |
CY2022Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.00 | |
CY2022Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.00 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.14 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.14 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.00 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.00 | ||
CY2023Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.07 | |
CY2022Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.00 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.14 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.00 | ||
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
345508 | usd |
CY2023Q1 | TENK |
Adjustments To Retained Earnings Remeasurement Of Ordinary Shares Subject To Redemption
AdjustmentsToRetainedEarningsRemeasurementOfOrdinarySharesSubjectToRedemption
|
-759647 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
611725 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
197586 | usd |
CY2023Q2 | TENK |
Adjustments To Retained Earnings Remeasurement Of Ordinary Shares Subject To Redemption
AdjustmentsToRetainedEarningsRemeasurementOfOrdinarySharesSubjectToRedemption
|
-815850 | usd |
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
616296 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1968 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-10113 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-10113 | usd |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-10113 | usd |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-10113 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-10113 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-10113 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
1228021 | usd | |
TENK |
Interest Income On Investments Held In Trust
InterestIncomeOnInvestmentsHeldInTrust
|
1575497 | usd | |
us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
3643 | usd | |
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
82064 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-269055 | usd | |
us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
349975 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
349975 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
80920 | usd | |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
289175 | usd |
CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
370095 | usd |
TENK |
Remeasurement Of Ordinary Shares Subject To Redemption
RemeasurementOfOrdinarySharesSubjectToRedemption
|
1575497 | usd | |
TENK |
Deferred Offering Costs Included In Accrued Expenses
DeferredOfferingCostsIncludedInAccruedExpenses
|
78312 | usd | |
TENK |
Deferred Offering Costs Included In Due To Related Party
DeferredOfferingCostsIncludedInDueToRelatedParty
|
5848 | usd | |
CY2022Q4 | TENK |
Condition For Future Business Combination Use Of Proceeds Percentage
ConditionForFutureBusinessCombinationUseOfProceedsPercentage
|
0.80 | pure |
CY2022Q4 | TENK |
Condition For Future Business Combination Threshold Percentage Ownership
ConditionForFutureBusinessCombinationThresholdPercentageOwnership
|
0.50 | pure |
CY2022Q4 | TENK |
Redemption Limit Percentage Without Prior Written Consent
RedemptionLimitPercentageWithoutPriorWrittenConsent
|
0.15 | pure |
CY2022Q4 | TENK |
Percentage Obligation To Redeem Public Shares If Entity Does Not Complete Business Combination
PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination
|
1 | pure |
CY2022Q4 | TENK |
Percentage Obligation To Redeem Public Shares If Entity Does Not Complete Business Combination
PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination
|
1 | pure |
CY2022Q4 | TENK |
Maximum Allowed Dissolution Expenses
MaximumAllowedDissolutionExpenses
|
100000 | usd |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_848_eus-gaap--UseOfEstimates_zq2wKenESRfb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><i><span id="xdx_863_zm7M69SxHOZf">Use of Estimates</span></i></b></span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.5in; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.</span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.5in; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.5in; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.5in; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> | ||
CY2022Q4 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
0 | usd |
CY2021Q4 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
0 | usd |
CY2023Q2 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
0 | usd |
CY2022Q4 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
0 | usd |
CY2023Q2 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | usd |
CY2022Q2 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | usd |
CY2023Q2 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
0 | usd |
CY2022Q2 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
0 | usd |
CY2022Q4 | us-gaap |
Shares Subject To Mandatory Redemption Settlement Terms Amount
SharesSubjectToMandatoryRedemptionSettlementTermsAmount
|
66000000 | usd |
CY2022Q4 | TENK |
Proceeds Allocated To Public Rights
ProceedsAllocatedToPublicRights
|
-1056000 | usd |
CY2022Q4 | TENK |
Offering Costs Allocated Ordinary Shares Subject To Redemption
OfferingCostsAllocatedOrdinarySharesSubjectToRedemption
|
-4755805 | usd |
CY2022Q4 | TENK |
Temporary Equity Accrued Interest In Trust
TemporaryEquityAccruedInterestInTrust
|
7624825 | usd |
CY2022Q4 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
67813020 | usd |
CY2023Q1 | TENK |
Temporary Equity Accrued Interest In Trust
TemporaryEquityAccruedInterestInTrust
|
759647 | usd |
CY2023Q1 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
68572667 | usd |
CY2023Q2 | TENK |
Temporary Equity Accrued Interest In Trusts
TemporaryEquityAccruedInterestInTrusts
|
815850 | usd |
CY2023Q2 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
69388517 | usd |
us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_zrPrs9aqTqp3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><i><span id="xdx_865_z5WCcOreuyU3">Concentration of Credit Risk</span></i></b></span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.5in; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_90C_eus-gaap--CashFDICInsuredAmount_iI_c20230630_zGkkZSWcph6l" title="FDIC insured amount">250,000</span>. The Company has not experienced losses on this account.</span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; text-indent: 0.5in; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> | ||
CY2023Q2 | us-gaap |
Cash Fdic Insured Amount
CashFDICInsuredAmount
|
250000 | usd |
CY2021Q4 | us-gaap |
Sale Of Stock Price Per Share
SaleOfStockPricePerShare
|
12.00 | |
CY2023Q2 | us-gaap |
Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
|
30000 | usd |
us-gaap |
Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
|
60000 | usd | |
CY2022Q2 | us-gaap |
Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
|
0 | usd |
us-gaap |
Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
|
0 | usd | |
CY2023Q2 | us-gaap |
Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
|
0 | usd |
CY2022Q4 | us-gaap |
Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
|
0 | usd |
CY2023Q2 | us-gaap |
Share Price
SharePrice
|
10.00 | |
CY2023Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | shares |
CY2023Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2023Q2 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2023Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
2416000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
2416000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
2416000 | shares |
CY2023Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
2416000 | shares |
us-gaap |
Stock Issued During Period Shares Share Based Compensation Forfeited
StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
|
225000 | shares | |
CY2022Q4 | us-gaap |
Payments For Underwriting Expense
PaymentsForUnderwritingExpense
|
2922480 | usd |